Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
ItalyStudy on Batoclimab for Treating Patients with Active Thyroid Eye Disease
ItalyStudy Comparing Alectinib and Crizotinib for Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer
ItalyStudy of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer
ItalyStudy of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health
ItalyStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
ItalyStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
ItalyStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
ItalyStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
ItalyStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
ItalyStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
ItalyStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
